ASAKO SHIN: Open Payments
NPI 1558674069 · MADERA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,036 in 56 payments from 12 companies in 2025. Trend: 2023 $1,404 · 2024 $1,776 · 2025 $1,036
Food & beverage: $1,036
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $221 |
| Amgen Inc. | 13 | $210 |
| Merck Sharp & Dohme LLC | 8 | $175 |
| Novartis Pharmaceuticals Corporation | 15 | $160 |
| PFIZER INC. | 5 | $81 |
| Boston Scientific Corporation | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| CARDIVA MEDICAL, INC. | 1 | $27 |
| SCPHARMACEUTICALS INC. | 1 | $22 |
| Abbott Laboratories | 1 | $19 |
Products named: JARDIANCE, VERQUVO, LEQVIO, Repatha, ELIQUIS, WATCHMAN FLX, Kerendia, OPTOWIRE.
Industry payments across CA — which companies pay providers there.
